New US tariff plans on drug imports could shake the $13 billion Indian pharma exports to their core, jeopardising generics access and investor confidence alike. #Pharma #US #tradewar Read more »
India is witnessing a dramatic rise in diabetic cases, raising questions about the role of pharmaceutical companies in deciding diabetes thresholds. #diabetes #pharma Read more »
The government may water down NMC regulations for professionals in the face of opposition from medical community. #medical #news #NMC #pharmaceuticals Read more »
The Indian pharma industry is expected to grow from $50 billion this year to $130 billion by 2030 and $450 billion by 2047. Read more »